Annual revenue:
$29.55B-$278.56M(-0.93%)Summary
- As of today (April 18, 2025), TAK annual revenue is $29.55 billion, with the most recent change of -$278.56 million (-0.93%) on March 31, 2024.
- During the last 3 years, TAK annual revenue has fallen by -$618.36 million (-2.05%).
- TAK annual revenue is now -7.06% below its all-time high of $31.79 billion, reached on March 31, 2022.
Performance
TAK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$7.50B-$416.58M(-5.26%)Summary
- As of today (April 18, 2025), TAK quarterly revenue is $7.50 billion, with the most recent change of -$416.58 million (-5.26%) on December 1, 2024.
- Over the past year, TAK quarterly revenue has dropped by -$416.58 million (-5.26%).
- TAK quarterly revenue is now -13.54% below its all-time high of $8.68 billion, reached on June 30, 2021.
Performance
TAK Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$30.25B-$24.65M(-0.08%)Summary
- As of today (April 18, 2025), TAK TTM revenue is $30.25 billion, with the most recent change of -$24.65 million (-0.08%) on December 1, 2024.
- Over the past year, TAK TTM revenue has dropped by -$24.65 million (-0.08%).
- TAK TTM revenue is now -4.87% below its all-time high of $31.80 billion, reached on March 31, 2022.
Performance
TAK TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TAK Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.9% | -5.3% | -0.1% |
| 3 y3 years | -2.0% | +3.6% | +1.6% |
| 5 y5 years | +56.2% | +3.1% | +0.3% |
TAK Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.1% | at low | -5.3% | +5.9% | -4.9% | +2.4% |
| 5 y | 5-year | -7.1% | at low | -13.5% | +5.9% | -4.9% | +2.4% |
| alltime | all time | -7.1% | +267.0% | -13.5% | +109.0% | -4.9% | +689.5% |
Takeda Pharmaceutical Company Limited Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $7.50B(-5.3%) | $30.25B(-0.1%) |
| Sep 2024 | - | $7.92B(+2.2%) | $30.27B(+2.4%) |
| Jun 2024 | - | $7.75B(+9.4%) | $29.58B(+0.1%) |
| Mar 2024 | $29.55B(-0.9%) | $7.08B(-5.9%) | $29.54B(-0.5%) |
| Dec 2023 | - | $7.53B(+4.2%) | $29.70B(-0.8%) |
| Sep 2023 | - | $7.22B(-6.4%) | $29.95B(-0.1%) |
| Jun 2023 | - | $7.71B(+6.6%) | $29.99B(+0.7%) |
| Mar 2023 | $29.83B(-6.2%) | $7.24B(-6.9%) | $29.78B(-0.9%) |
| Dec 2022 | - | $7.78B(+7.2%) | $30.06B(-0.5%) |
| Sep 2022 | - | $7.26B(-3.3%) | $30.21B(-1.4%) |
| Jun 2022 | - | $7.51B(-0.2%) | $30.63B(-3.7%) |
| Mar 2022 | $31.79B(+5.4%) | $7.52B(-5.2%) | $31.80B(+0.8%) |
| Dec 2021 | - | $7.93B(+3.3%) | $31.55B(-0.3%) |
| Sep 2021 | - | $7.68B(-11.5%) | $31.64B(+0.8%) |
| Jun 2021 | - | $8.68B(+19.3%) | $31.39B(+4.1%) |
| Mar 2021 | $30.17B(-0.4%) | $7.27B(-9.2%) | $30.17B(+0.6%) |
| Dec 2020 | - | $8.01B(+7.8%) | $29.98B(+0.4%) |
| Sep 2020 | - | $7.43B(-0.2%) | $29.87B(-0.4%) |
| Jun 2020 | - | $7.45B(+5.2%) | $30.00B(-0.9%) |
| Mar 2020 | $30.28B(+60.1%) | $7.09B(-10.3%) | $30.28B(+1.9%) |
| Dec 2019 | - | $7.90B(+4.5%) | $29.70B(+13.2%) |
| Sep 2019 | - | $7.56B(-2.1%) | $26.23B(+16.4%) |
| Jun 2019 | - | $7.73B(+18.6%) | $22.53B(+19.0%) |
| Mar 2019 | $18.92B(+18.4%) | $6.51B(+47.0%) | $18.93B(+17.5%) |
| Dec 2018 | - | $4.43B(+14.6%) | $16.12B(+0.7%) |
| Sep 2018 | - | $3.86B(-6.3%) | $16.01B(-0.3%) |
| Jun 2018 | - | $4.12B(+11.5%) | $16.05B(+0.6%) |
| Mar 2018 | $15.98B(-0.2%) | $3.70B(-14.4%) | $15.96B(+0.2%) |
| Dec 2017 | - | $4.32B(+10.7%) | $15.92B(+0.4%) |
| Sep 2017 | - | $3.91B(-3.2%) | $15.86B(-1.0%) |
| Jun 2017 | - | $4.03B(+10.2%) | $16.03B(+0.1%) |
| Mar 2017 | $16.02B(+6.3%) | $3.66B(-14.1%) | $16.01B(+0.4%) |
| Dec 2016 | - | $4.26B(+4.6%) | $15.95B(+1.5%) |
| Sep 2016 | - | $4.07B(+1.3%) | $15.71B(+2.1%) |
| Jun 2016 | - | $4.02B(+11.8%) | $15.39B(+2.3%) |
| Mar 2016 | $15.06B | $3.59B(-10.8%) | $15.05B(-0.5%) |
| Dec 2015 | - | $4.03B(+7.5%) | $15.13B(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $3.75B(+1.8%) | $15.37B(-3.1%) |
| Jun 2015 | - | $3.68B(+0.1%) | $15.86B(-2.1%) |
| Mar 2015 | $16.26B(-3.7%) | $3.67B(-14.0%) | $16.21B(-1.6%) |
| Dec 2014 | - | $4.27B(+0.9%) | $16.47B(-1.8%) |
| Sep 2014 | - | $4.24B(+5.2%) | $16.76B(+0.1%) |
| Jun 2014 | - | $4.02B(+2.3%) | $16.75B(-0.8%) |
| Mar 2014 | $16.89B(-10.4%) | $3.94B(-13.9%) | $16.88B(-0.4%) |
| Dec 2013 | - | $4.57B(+8.1%) | $16.94B(-2.2%) |
| Sep 2013 | - | $4.23B(+1.7%) | $17.33B(-4.0%) |
| Jun 2013 | - | $4.15B(+4.0%) | $18.05B(-4.3%) |
| Mar 2013 | $18.84B(-1.5%) | $3.99B(-19.3%) | $18.86B(-4.2%) |
| Dec 2012 | - | $4.95B(+0.2%) | $19.68B(-2.7%) |
| Sep 2012 | - | $4.94B(-0.5%) | $20.22B(+2.5%) |
| Jun 2012 | - | $4.97B(+3.2%) | $19.72B(+3.1%) |
| Mar 2012 | $19.12B(+16.0%) | $4.81B(-12.4%) | $19.13B(+3.8%) |
| Dec 2011 | - | $5.49B(+23.7%) | $18.43B(+6.0%) |
| Sep 2011 | - | $4.44B(+1.4%) | $17.38B(+1.5%) |
| Jun 2011 | - | $4.38B(+6.5%) | $17.12B(+3.2%) |
| Mar 2011 | $16.48B(+4.3%) | $4.11B(-7.5%) | $16.59B(+2.4%) |
| Dec 2010 | - | $4.44B(+6.3%) | $16.20B(+1.9%) |
| Sep 2010 | - | $4.18B(+8.5%) | $15.91B(+1.0%) |
| Jun 2010 | - | $3.85B(+3.5%) | $15.75B(-0.2%) |
| Mar 2010 | $15.80B(+2.1%) | $3.72B(-10.2%) | $15.79B(+0.9%) |
| Dec 2009 | - | $4.15B(+2.9%) | $15.65B(+0.1%) |
| Sep 2009 | - | $4.03B(+3.5%) | $15.64B(+1.3%) |
| Jun 2009 | - | $3.89B(+8.4%) | $15.45B(+33.7%) |
| Mar 2009 | $15.47B(+28.2%) | $3.59B(-13.2%) | $11.56B(+45.0%) |
| Dec 2008 | - | $4.14B(+7.9%) | $7.97B(+107.9%) |
| Sep 2008 | - | $3.83B | $3.83B |
| Mar 2008 | $12.06B(+8.1%) | - | - |
| Mar 2007 | $11.16B(+4.1%) | - | - |
| Mar 2006 | $10.72B(+2.5%) | - | - |
| Mar 2005 | $10.46B(+8.6%) | - | - |
| Mar 2004 | $9.64B(+12.2%) | - | - |
| Mar 2003 | $8.59B(+6.7%) | - | - |
| Mar 2002 | $8.05B(-7.8%) | - | - |
| Mar 2001 | $8.73B(+4.9%) | - | - |
| Mar 2000 | $8.32B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual revenue?
- What is the all time high annual revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual revenue year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly revenue?
- What is the all time high quarterly revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly revenue year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM revenue?
- What is the all time high TTM revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM revenue year-on-year change?
What is Takeda Pharmaceutical Company Limited annual revenue?
The current annual revenue of TAK is $29.55B
What is the all time high annual revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual revenue is $31.79B
What is Takeda Pharmaceutical Company Limited annual revenue year-on-year change?
Over the past year, TAK annual revenue has changed by -$278.56M (-0.93%)
What is Takeda Pharmaceutical Company Limited quarterly revenue?
The current quarterly revenue of TAK is $7.50B
What is the all time high quarterly revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly revenue is $8.68B
What is Takeda Pharmaceutical Company Limited quarterly revenue year-on-year change?
Over the past year, TAK quarterly revenue has changed by -$416.58M (-5.26%)
What is Takeda Pharmaceutical Company Limited TTM revenue?
The current TTM revenue of TAK is $30.25B
What is the all time high TTM revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM revenue is $31.80B
What is Takeda Pharmaceutical Company Limited TTM revenue year-on-year change?
Over the past year, TAK TTM revenue has changed by -$24.65M (-0.08%)